MedTrace Logo

Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

NCT02484040 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2017-06-05

No results posted yet for this study

Summary

The investigators compare two-week course of chemoradiation (33 Gy in 10 fractions with oral capecitabine) and conventional chemoradiation (50.4 Gy in 28 fractions with 5-FU and leucovorin) in this randomized trial.

Conditions

  • Response to Toxin
  • Toxicity
  • Recurrence

Interventions

RADIATION

Two-week course of radiation

33 Gy in 10 fractions for 2 weeks

DRUG

Two-week course of radiation

oral capecitabine, 825mg/m2, bid

Sponsors & Collaborators

  • Jong Hoon Lee

    lead OTHER

Principal Investigators

  • Jong Hoon Lee, MD · St. Vincent's Hospital, The Catholic University of Kora

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2019-07-31
Completion
2021-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02484040 on ClinicalTrials.gov